Laser treatment
This is the standard treatment for diabetic retinopathy and has the longest track record and is still the most applied treatment.
For Maculopathy (CMO): Focal laser and /or a grid type laser are applied to the centre of the retina to decrease the thickening. Anything between 1–150 laser shots are applied in one visit.
For Proliferative Diabetic Retinopathy: Peripheral laser treatment is applied to the retina to reduce and eliminate the newly developed blood vessels. The laser destroys some of the outer part of the retina leading to a decreased need for oxygen in the eye and resolving the problem of the new blood vessels. 1200–2000 laser shots are applied, in one or more sessions.
Anti-VEGF intravitreal injections
For Maculopathy (CMO): Ranibizumab was approved for the use in CMO. Ranibizumab blocks a growth factor protein in the eye and stops blood vessels leaking and new blood vessels from growing, although only temporarily.
For Proliferative Diabetic Retinopathy: Ranibizumab injections lead to temporary closure of the new blood vessels caused by Proliferative Diabetic Retinopathy.
Vitrectomy
An operation where the gel in the eye (vitreous) is removed by a cutting device.